{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:42:22Z","timestamp":1788536542212,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017160","name":"Beni Suef University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017160","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Psoriasis is one of the dermatological autoimmune diseases that involve cracking, redness, bleeding and inflammation on the surface of the skin. Sulfasalazine (SUL) is an immunity suppressing and anti-phlogistic drug. Pentoxifylline (PTN) is an immunosuppressant and vasodilator. So, the two drugs are co-administered together in the treatment protocol for psoriasis. No chromatographic analytical method was developed in the literature for the quantitative determination of SUL and PTN in their binary mixture and spiked human plasma. So, this work\u2019s goal is to establish an environmentally friendly and selective TLC method for quantitative assay of sulfasalazine and pentoxifylline in their common mixture and spiked human plasma samples. The separation was successfully obtained using a developing system consisting of ethanol: ethyl acetate (7: 3, v\/v) and 270 nm as UV scanning wavelength. Paracetamol was chosen as an internal standard to correct sampling minute variations. The obtained retardation factor values were 0.02, 0.43, 0.68 and 0.8 for plasma, pentoxifylline, sulfasalazine and paracetamol, in the same order. The resulting LLOQ for SUL and PTN were 0.3 and 0.2 \u00b5g\/band, respectively. Three environmental friendliness assessment tools including analytical greenness metric approach (AGREE), eco-scale assessments, and green analytical procedure index (GAPI) were applied to evaluate the environmental safety characters of the suggested method. Validation parameters were within the accepted ranges when checked according to US-FDA guidelines to for bioanalytical method validation.<\/jats:p>","DOI":"10.1186\/s13065-025-01531-0","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T06:04:11Z","timestamp":1749794651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Eco-conscious TLC assay for dual psoriasis drugs in plasma: a green analytical approach"],"prefix":"10.1186","volume":"19","author":[{"given":"Maimana A.","family":"Magdy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basma H.","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehal F.","family":"Farid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nessreen S.","family":"Abdelhamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"key":"1531_CR1","unstructured":"The British Pharmacopoeia. Medicines and healthcare products regulatory agency. 2013.\u200f London, UK,"},{"key":"1531_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-008055232-3.63921-2","author":"J George","year":"2008","unstructured":"George J, Abel P. Pentoxifylline. xPharm. 2008. https:\/\/doi.org\/10.1016\/B978-008055232-3.63921-2.","journal-title":"xPharm"},{"key":"1531_CR3","first-page":"223","volume":"42","author":"V Christova-Bagdassarian","year":"2007","unstructured":"Christova-Bagdassarian V, Angelov T, Atanassova M. UV-spectrometric and high performance liquid chromatographic determination of pentoxifylline in workplace air. J Chem Technol Metall. 2007;42:223\u20137.","journal-title":"J Chem Technol Metall"},{"key":"1531_CR4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.4236\/ajac.2016.72015","volume":"7","author":"AM Mahmoud","year":"2016","unstructured":"Mahmoud AM, AlQahtani SA. Spectrophotometric study for the reaction of pentoxifylline hydrochloride with 1, 2-naphthoquinone-4-sulphonate: kinetics, mechanism and application for development of high-throughput kinetic microwell assay for pentoxifylline in quality control laboratory. American J Anal Chem. 2016;7:179\u201391.","journal-title":"American J Anal Chem"},{"key":"1531_CR5","first-page":"608","volume":"4","author":"BG Tsvetkova","year":"2012","unstructured":"Tsvetkova BG, Pencheva IP, Peikov PT. Simultaneous determination of pentoxifylline and its impurities in tablet dosage forms by RP-HPLC. Der Pharma Chem. 2012;4:608\u201312.","journal-title":"Der Pharma Chem"},{"key":"1531_CR6","first-page":"211","volume":"51","author":"MA Korany","year":"2013","unstructured":"Korany MA, Haggag RS, Ragab MA, Elmallah OA. A validated stability indicating DAD\u2013HPLC method for determination of pentoxifylline in presence of its pharmacopeial related substances. Bull Fac Pharm Cairo Univ. 2013;51:211\u20139.","journal-title":"Bull Fac Pharm Cairo Univ"},{"key":"1531_CR7","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3390\/chromatography2040642","volume":"2","author":"T Purvis","year":"2015","unstructured":"Purvis T. Simultaneous high performance liquid chromatography assay of pentoxifylline, mupirocin, itraconazole, and fluticasone propionate in Humco\u2122 Lavare wound base. Chromatogr. 2015;2:642\u201354.","journal-title":"Chromatogr"},{"key":"1531_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jchromb.2017.06.043","volume":"1061","author":"KS Italiya","year":"2017","unstructured":"Italiya KS, Sharma S, Kothari I, Chitkara D, Mittal A. Simultaneous estimation of lisofylline and pentoxifylline in rat plasma by high performance liquid chromatography-photodiode array detector and its application to pharmacokinetics in rat. J Chromatogr B. 2017;1061:49\u201356.","journal-title":"J Chromatogr B"},{"key":"1531_CR9","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1093\/jaoac\/84.4.1258","volume":"84","author":"I Vovk","year":"2001","unstructured":"Vovk I, Simonovska B. TLC determination of mebendazol and pentoxifylline as residues on pharmaceutical equipment surfaces. J AOAC Int. 2001;84:1258\u201364.","journal-title":"J AOAC Int"},{"key":"1531_CR10","first-page":"527","volume":"2","author":"RM Jeswani","year":"2009","unstructured":"Jeswani RM, Sinha PK, Topagi KS, Damle MC. A validated stability indicating HPTLC method for determination of pentoxifylline in bulk and pharmaceutical formulation. Res J Pharm Technol. 2009;2:527\u201330.","journal-title":"Res J Pharm Technol"},{"key":"1531_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/B978-008055232-3.62696-0","author":"N Corea","year":"2007","unstructured":"Corea N. Sulfasalazine. xPharm. 2007. https:\/\/doi.org\/10.1016\/B978-008055232-3.62696-0.","journal-title":"xPharm"},{"key":"1531_CR12","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/jaoacint\/qsab103","volume":"105","author":"NS Abdelwhab","year":"2022","unstructured":"Abdelwhab NS, Habib NM, Abdelrahman MM, Mahmoud HM, Emam AA. Determination of sulphasalazine and its related compounds by simple, smart, validated, green spectrophotometric methods. J AOAC Int. 2022;105:352\u201361.","journal-title":"J AOAC Int"},{"key":"1531_CR13","doi-asserted-by":"publisher","first-page":"113551","DOI":"10.1039\/C6RA20223C","volume":"6","author":"S Sadeghi","year":"2022","unstructured":"Sadeghi S, Oliaei S. Optimization of ionic liquid based dispersive liquid\u2013liquid microextraction combined with dispersive micro-solid phase extraction for the spectrofluorimetric determination of sulfasalazine in aqueous samples by response surface methodology. RSC adv. 2022;6:113551\u201360.","journal-title":"RSC adv"},{"key":"1531_CR14","doi-asserted-by":"publisher","first-page":"4625","DOI":"10.5958\/0974-360X.2020.00814.8","volume":"13","author":"SW Al-Hasnawi","year":"2020","unstructured":"Al-Hasnawi SW, Nasr MS. Spectrophotometric determination of Sulfasalazine drug in pure and Pharmaceutical preparation using sodium 1, 2-naphthoquinone-4-sulfonate (NQS) reagent. Res J Pharm Technol. 2020;13:4625\u20138.","journal-title":"Res J Pharm Technol"},{"key":"1531_CR15","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.3390\/w11081581","volume":"11","author":"M Hryniewicka","year":"2019","unstructured":"Hryniewicka M, Starczewska B, Go\u0142\u0119biewska A. Determination of budesonide and sulfasalazine in water and wastewater samples using DLLME-SFO-HPLC-UV method. Water. 2019;11:1581.","journal-title":"Water"},{"key":"1531_CR16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3797\/scipharm.1311-15","volume":"82","author":"B Saini","year":"2014","unstructured":"Saini B, Bansal G. Degradation study on sulfasalazine and a validated HPLC-UV method for its stability testing. Sci Pharm. 2014;82:295\u2013306.","journal-title":"Sci Pharm"},{"key":"1531_CR17","first-page":"122","volume":"33","author":"S Joseph","year":"2022","unstructured":"Joseph S, Khera S, Menon S. Simultaneous determination of methotrexate and sulfasalazine in plasma by HPLC\u2013DAD. LCGC North Am. 2022;33:122\u201338.","journal-title":"LCGC North Am"},{"key":"1531_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2022.123246","volume":"1198","author":"V Tsamis","year":"2022","unstructured":"Tsamis V, Tsanaktsidou E, Karavasili C, Zacharis CK, Bouropoulos N, Fatouros DG, Markopoulou CK. Development and validation of HPLC-DAD and LC-(ESI)\/MS methods for the determination of sulfasalazine, mesalazine and hydrocortisone 21-acetate in tablets and rectal suppositories: In vitro and ex vivo permeability studies. J Chromatogr B. 2022;1198: 123246.","journal-title":"J Chromatogr B"},{"key":"1531_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.4804","volume":"34","author":"MM Abdelrahman","year":"2020","unstructured":"Abdelrahman MM, Habib NM, Emam AA, Mahmoud HM, Abdelwhab NS. Chromatographic determination of sulfasalazine and its active metabolites: greenness assessment and application to spiked human plasma. Biomed Chromatogr. 2020;34: e4804.","journal-title":"Biomed Chromatogr"},{"key":"1531_CR20","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1556\/AChrom.27.2015.4.4","volume":"27","author":"A Kwiecie\u0144","year":"2015","unstructured":"Kwiecie\u0144 A, Pi\u0105tek K, \u017bmudzki P, Krzek J. TLC\u2014densitometric determination of sulfasalazine and its possible impurities in pharmaceutical preparations. Acta Chromatogr. 2015;27:623\u201335.","journal-title":"Acta Chromatogr"},{"key":"1531_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3109\/09546630903460260","volume":"22","author":"M El-Mofty","year":"2011","unstructured":"El-Mofty M, El-Darouti M, Rasheed H, Bassiouny DA, Abdel-Halim M, Zaki NS, El-Hanafy G, El-Hadid H, Azzam O, El-Ramly A, Fawzy M. Sulfasalazine and pentoxifylline in psoriasis: a possible safe alternative. J Dermat Treat. 2011;22:31\u20137.","journal-title":"J Dermat Treat"},{"key":"1531_CR22","unstructured":"Healthlinee. Everything you need to know about psoriasis. 2023; https:\/\/www.healthline.com\/health\/psoriasis. Accessed 6 Feb 2023."},{"key":"1531_CR23","doi-asserted-by":"publisher","first-page":"640","DOI":"10.4103\/0378-6323.168341","volume":"81","author":"D Dogra","year":"2015","unstructured":"Dogra D, Dogra NK, Gupta N, Gupta V. Sulfasalazine and pentoxifylline, a new adjuvant in young pemphigus patients: a pilot study. Ind J Dermatol Venereol Leprol. 2015;81:640\u20132.","journal-title":"Ind J Dermatol Venereol Leprol"},{"key":"1531_CR24","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1365-2133.2009.09208.x","volume":"161","author":"M El-Darouti","year":"2009","unstructured":"El-Darouti M, Marzouk S, Abdel Hay R, El Tawdy A, Fawzy M, Leheta T, Gammaz H, Al GN. The use of sulfasalazine and pentoxifylline (low-cost antitumour necrosis factor drugs) as adjuvant therapy for the treatment of pemphigus vulgaris: a comparative study. British J Dermat. 2009;161:313\u20139.","journal-title":"British J Dermat"},{"key":"1531_CR25","unstructured":"Mayo Clinic. Pemphigus. 2023; https:\/\/www.mayoclinic.org\/diseases-conditions\/pemphigus\/symptoms-causes\/syc-20350404. Accessed 6 Feb 2023."},{"key":"1531_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/jaoacint\/qsad097","volume":"107","author":"MA Magdy","year":"2024","unstructured":"Magdy MA, Farid NF, Anwar BH, Abdelhamid NS. Smart multivariate spectrophotometric determination of two co-administered autoimmune drugs; sulfasalazine and pentoxifylline; in bulk and spiked human plasma. J AOAC Int. 2024;107:189\u201395.","journal-title":"J AOAC Int"},{"key":"1531_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.trac.2012.03.013","volume":"37","author":"A Ga\u0142uszka","year":"2012","unstructured":"Ga\u0142uszka A, Migaszewski ZM, Konieczka P, Namie\u015bnik J. Analytical eco-scale for assessing the greenness of analytical procedures. TrAC Trends Anal Chem. 2012;37:61\u201372.","journal-title":"TrAC Trends Anal Chem"},{"key":"1531_CR28","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.talanta.2018.01.013","volume":"181","author":"J P\u0142otka-Wasylka","year":"2018","unstructured":"P\u0142otka-Wasylka J. A new tool for the evaluation of the analytical procedure: green analytical procedure index. Talanta. 2018;181:204\u20139.","journal-title":"Talanta"},{"key":"1531_CR29","doi-asserted-by":"publisher","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","volume":"92","author":"F Pena-Pereira","year":"2020","unstructured":"Pena-Pereira F, Wojnowski W, Tobiszewski M. AGREE\u2014analytical GREEnness metric approach and software. Anal Chem. 2020;92:10076\u201382.","journal-title":"Anal Chem"},{"key":"1531_CR30","unstructured":"US FDA, Department of health and human services. Bioanalytical method validation guidance for industry.\u200f 2018."},{"key":"1531_CR31","doi-asserted-by":"publisher","first-page":"105582","DOI":"10.1016\/j.microc.2020.105582","volume":"159","author":"MM Abdelrahman","year":"2020","unstructured":"Abdelrahman MM, Abdelwahab NS, Hegazy MA, Fares MY. Determination of the abused intravenously self-administered madness drops (Tropicamide) by liquid chromatography in rat plasma; an application to pharmacokinetic study and greenness profile assessment. Microchem J. 2020;159:105582.","journal-title":"Microchem J"},{"key":"1531_CR32","doi-asserted-by":"publisher","first-page":"349","DOI":"10.4155\/bio-2018-0191","volume":"11","author":"MY Fares","year":"2019","unstructured":"Fares MY, Abdelwahab NS, Abdelrahman MM, Abdel-Rahman HM. Determination of sofosbuvir with two co-administered drugs; paracetamol and DL-methionine by two chromatographic methods. Application to a pharmacokinetic study. Bioanalysis. 2019;11:349\u201364.","journal-title":"Bioanalysis"},{"key":"1531_CR33","doi-asserted-by":"crossref","unstructured":"Abbas SS, Wagieh NE, Abdelkawy M, Abdelrahman MM. Simultaneous determination of diloxanide furoate and metronidazole in presence of diloxanide furoate degradation products. J AOAC. 2011; Int 94: 1427\u20131439.\u200f\u200f","DOI":"10.5740\/jaoacint.10-286"},{"key":"1531_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.teac.2023.e00202","volume":"2023","author":"MS Imam","year":"2023","unstructured":"Imam MS, Abdelrahman MM. How environmentally friendly is the analytical process? A paradigm overview of ten greenness assessment metric approaches for analytical methods. Trends Environ Anal Chem. 2023;2023: e00202.","journal-title":"Trends Environ Anal Chem"},{"key":"1531_CR35","volume-title":"High-performance thin-layer chromatography (HPTLC)","author":"M Srivastava","year":"2010","unstructured":"Srivastava M. High-performance thin-layer chromatography (HPTLC). Heidelberg Dordecht: Springer; 2010."}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-025-01531-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-025-01531-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-025-01531-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T06:04:13Z","timestamp":1749794653000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcchem.biomedcentral.com\/articles\/10.1186\/s13065-025-01531-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1531"],"URL":"https:\/\/doi.org\/10.1186\/s13065-025-01531-0","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,13]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research ethical commission of the BeniSuef University\u2014Faculty of Pharmacy (BeniSuef, Egypt) has accepted this work, with serial number REC-H-PhBSU-24013. Every participant gave their informed consent. The Helsinki declaration is followed to in this investigation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"166"}}